HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 112 filers reported holding HARROW HEALTH INC in Q2 2023. The put-call ratio across all filers is 1.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $278,218 | +19.0% | 19,361 | +57.7% | 0.00% | – |
Q2 2023 | $233,716 | +238.3% | 12,275 | +276.0% | 0.00% | – |
Q1 2023 | $69,087 | +788.1% | 3,265 | +519.5% | 0.00% | – |
Q4 2022 | $7,779 | -100.0% | 527 | -67.5% | 0.00% | – |
Q3 2022 | $19,578,000 | +272.5% | 1,622 | +124.7% | 0.00% | – |
Q2 2022 | $5,256,000 | -6.5% | 722 | -12.4% | 0.00% | – |
Q1 2022 | $5,620,000 | +54.1% | 824 | +95.3% | 0.00% | – |
Q4 2021 | $3,646,000 | -11.1% | 422 | -6.4% | 0.00% | – |
Q3 2021 | $4,100,000 | -24.0% | 451 | -22.4% | 0.00% | – |
Q2 2021 | $5,397,000 | -76.8% | 581 | -83.1% | 0.00% | – |
Q1 2021 | $23,220,000 | -47.9% | 3,440 | -47.0% | 0.00% | – |
Q4 2020 | $44,556,000 | +49.6% | 6,495 | +21.9% | 0.00% | – |
Q3 2020 | $29,784,000 | +582.2% | 5,328 | +535.8% | 0.00% | – |
Q2 2020 | $4,366,000 | – | 838 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 3,343,817 | $40,360,000 | 16.67% |
Invenire Partners, LP | 453,794 | $5,477,293,000 | 8.38% |
Acuitas Investments, LLC | 337,949 | $4,079,000 | 4.23% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 188,539 | $2,276,000 | 2.47% |
Ophir Asset Management Pty Ltd | 1,714,464 | $20,694,000 | 1.88% |
Private Capital Management, LLC | 1,029,356 | $12,424,000 | 1.80% |
Birchview Capital, LP | 180,000 | $2,173,000 | 1.53% |
Diametric Capital, LP | 224,090 | $2,705,000 | 1.36% |
Uniplan Investment Counsel, Inc. | 694,257 | $8,379,000 | 0.64% |
EAM Investors, LLC | 224,046 | $2,704,000 | 0.59% |